Clinuvel Pharmaceuticals buy dokem
Start price
30.09.16
/
50%
€4.35
Target price
30.03.17
€9.50
Performance (%)
15.31%
End price
30.03.17
€5.02
Summary
This prediction ended on 30.03.17 with a price of €5.02. The prediction had a final performance of 15.31%. dokem has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | 3.478% | 3.478% | 5.195% | -52.831% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by dokem for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
dokem stimmt der Buy-Einschätzung von ValueFox zu
dokem stimmt am 30.09.2016 der Buy-Einschätzung von ValueFox mit dem Kursziel 12,6€ zu.Überschrift: Clinuvel: "strong buy" nach erfolgreichem Markteintritt
(Laufzeit überschritten)


